Alexandra Herman
Overview
Explore the profile of Alexandra Herman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herman A, Chung K
Plast Reconstr Surg
. 2024 Aug;
154(3):467-471.
PMID: 39196859
No abstract available.
2.
Benitez X, Aragon K, Jakeman B, Bachyrycz A, Iandiorio M, Meliniotis A, et al.
J Am Pharm Assoc (2003)
. 2023 Nov;
64(1):307-313.
PMID: 37952846
Background: Women with human immunodeficiency virus (HIV) are at risk of unintended pregnancy and may experience barriers to accessing contraception such as social stigma, concern for drug-drug interactions with HIV...
3.
Zamora M, Herman M, Herman A
J Am Pharm Assoc (2003)
. 2023 Nov;
64(2):547-550.
PMID: 37940103
Background: Medication use during pregnancy is common. Safety of fetal medication exposures is an important consideration for pregnancy and for pharmacologic management and care of newborns. Objectives: The objective of...
4.
Dale L, Trujillo V, Herman A, Sussman A, Espey E, Hofler L
J Am Pharm Assoc (2003)
. 2023 Oct;
64(1):235-244.e3.
PMID: 37890772
Background: States throughout the country are enacting legislation to authorize pharmacist prescribing of hormonal contraception to decrease barriers to access. Little is known about the process of state implementation of...
5.
Keenan M, Dillenburger K, Konrad M, Debetencourt N, Vuksan R, Kourea L, et al.
Behav Anal Pract
. 2023 Sep;
16(3):730.
PMID: 37680333
[This corrects the article DOI: 10.1007/s40617-022-00754-0.].
6.
Kasten Z, Lujan S, Jakeman B, Herman A, McClain M, Winters A, et al.
J Am Pharm Assoc (2003)
. 2023 Aug;
64(1):273-277.
PMID: 37598885
Background: The Centers for Disease Control and Prevention (CDC) recommend that all patients, regardless of gender identity or sexual orientation, should be offered family planning and contraceptive options without assumptions...
7.
Winters A, Jakeman B, Aragon K, Kasten Z, Bos A, Snyder J, et al.
J Int Assoc Provid AIDS Care
. 2022 Dec;
21:23259582221144449.
PMID: 36536987
The objective of this study was to examine contraception use and family planning discussions (FPD) in female people living with HIV (PLWH). A retrospective cohort study was conducted. Female PLWH...
8.
Keenan M, Dillenburger K, Konrad M, Debetencourt N, Vuksan R, Kourea L, et al.
Behav Anal Pract
. 2022 Nov;
:1-21.
PMID: 36406141
Behavior analysts are not recognized or regulated as a distinct profession in Europe. For the most part, European behavior analysts adhered to the standards set by the U.S.-based Behavior Analyst...
9.
Thaxton L, Clark E, Wu J, Herman A, Sussman A, Espey E
Contracept X
. 2021 Aug;
3():100069.
PMID: 34430846
Objective: In 2017, New Mexico approved an amendment allowing pharmacists to prescribe and dispense hormonal contraception. We interviewed rural New Mexico women to determine their perceptions of pharmacy access to...
10.
Herman A, McCauley G, Thaxton L, Borrego M, Sussman A, Espey E
J Am Pharm Assoc (2003)
. 2020 Apr;
60(5):e57-e63.
PMID: 32249171
Objectives: New Mexico is a large rural state with high rates of unintended pregnancy and limited access to contraception. In 2017, the New Mexico Pharmacist Prescriptive Authority Act was amended...